TWIST1 and urinary bladder carcinoma: Thus, we hypothesize that HMGN5 may interact with Hsp27 to affect IL-6-induced EMT and invasion in bladder cancer by modulating STAT3 phosphorylation and STAT3 targeting of the Twist promoter.